v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net loss $ (1,300,949) $ (1,161,602)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 306,051 315,100
Non-cash operating lease expense 11,967 12,232
Depreciation 466 467
Changes in operating assets and liabilities    
Prepaid expenses and other current assets 80,081 307,032
Accounts payable 99,095 (362,580)
Unearned grant revenue (278,628)
Accrued interest 50,422 58,152
Other accrued expenses 406,932 28,953
Operating lease liability (11,630) (12,570)
Net Cash Used In Operating Activities (357,565) (1,093,444)
Cash Flows From Financing Activities:    
Proceeds from issuance of convertible notes payable 110,000
Proceeds from issuance of convertible notes payable - related parties 225,000 455,000
Proceeds from issuance of common stock of majority-owned subsidiary 75,000 700,000
Repayment of short-term notes payable (80,128) (81,885)
Net Cash Provided By Financing Activities 329,872 1,073,115
Effect of exchange rates on cash and restricted cash 285 57
Net Decrease In Cash and Restricted Cash (27,408) (20,272)
Cash and Restricted Cash, Beginning of Period 251,291 489,726
Cash and Restricted Cash, End of Period 223,883 469,454
Cash and restricted cash consisted of the following:    
Cash 223,883 390,435
Restricted cash 79,019
Supplemental Disclosures of Cash Flow Information:    
Interest 4,305 2,829
Income taxes
Non-cash investing and financing activities:    
Conversion of 2022 Notes and related accrued interest to Series D-1 Preferred Stock 1,046,694
Conversion of 2025 Notes and related accrued interest to Series D-1 Preferred Stock $ 491,501